Class of Cancer Drugs May Have Potential as Chronic Obstructive Pulmonary Disease Treatment
January 17th 2020The ErbB inhibitors, gefitinib, erbstatin, and tryphostin AG825, inhibit a cell signaling process controlling the death-rate of neutrophils, immune cells, which cause damage to the lungs.
Read More
FDA Expands Labels for 2 Semaglutide Medications
January 17th 2020The medication is newly indication for reducing the risk of major adverse cardiovascular events (MACE) including cardiovascular death, nonfatal heart attack, or nonfatal stroke in adults with type 2 diabetes and established cardiovascular disease (CVD).
Read More
Pharmacy Technician Certification Board Launches New Requirements and Exam
January 16th 2020Starting January 2020, aspiring certified pharmacy technicians must complete a Pharmacy Technician Certification Exam-recognized education or training program, or have equivalent work experience before taking the exam.
Read More
Study: Long-Term Medication for Schizophrenia is Safe
January 16th 2020The researchers found that the likelihood of being hospitalized for a somatic disease was just as high during the periods when the patients were on antipsychotic drugs as when they were not; however, the differences in mortality were clear.
Read More
UNC Course Aims to Bridge Gap Between Research, Patient Care
January 16th 2020Pharmacy students at the University of North Carolina (UNC)-Chapel Hill Eshelman School of Pharmacy are attempting to understand why clinical research takes so long to impact patient care, as well as what they can do about it in their own practices.
Read More